Atossa Therapeutics, Inc. (ATOS)
NASDAQ: ATOS · IEX Real-Time Price · USD
1.160
-0.040 (-3.33%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Atossa Therapeutics Market Cap
Atossa Therapeutics has a market cap or net worth of $145.88 million as of July 2, 2024. Its market cap has increased by 29.78% in one year.
Market Cap
145.88M
Enterprise Value
61.81M
1-Year Change
29.78%
Ranking
Category
Stock Price
$1.16
Market Cap Chart
Since November 8, 2012, Atossa Therapeutics's market cap has increased from $62.00M to $145.88M, an increase of 135.29%. That is a compound annual growth rate of 7.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 150.90M | 36.81% |
| Dec 29, 2023 | 110.30M | 64.87% |
| Dec 30, 2022 | 66.90M | -66.98% |
| Dec 31, 2021 | 202.60M | 197.94% |
| Dec 31, 2020 | 68.00M | 375.52% |
| Dec 31, 2019 | 14.30M | 146.55% |
| Dec 31, 2018 | 5.80M | -17.14% |
| Dec 29, 2017 | 7.00M | 32.08% |
| Dec 30, 2016 | 5.30M | -45.36% |
| Dec 31, 2015 | 9.70M | -72.36% |
| Dec 31, 2014 | 35.10M | -16.03% |
| Dec 31, 2013 | 41.80M | -17.06% |
| Dec 31, 2012 | 50.40M | -18.71% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OptiNose | 150.63M |
| Vigil Neuroscience | 150.53M |
| Puma Biotechnology | 149.54M |
| Inventiva | 149.26M |
| Rigel Pharmaceuticals | 147.84M |
| Stereotaxis | 145.45M |
| ClearPoint Neuro | 145.33M |
| Caribou Biosciences | 144.51M |